Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring.
Front Immunol
; 15: 1373852, 2024.
Article
em En
| MEDLINE
| ID: mdl-38384474
ABSTRACT
[This corrects the article DOI 10.3389/fimmu.2023.1280580.].
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article